|
|
|
UNIVERSITE LIBRE DE BRUXELLES, BRUSSELS
25-29 OCTOBER 2004
- Molecular oncology as a basic for the development of new antineoplasic agents - The art of scientific writing - Impact of new technologies on drug discovery process : from gene to new chemical entity - New perspectives in preclinical drug discovery - Molecular and cellular pharmacology - Integration of the different screening procedures
|
|
|
|
|
|
Organized by:
|
|
PHARMED |
|
Invited Speakers:
|
|
Jacques DUMONT, ULB Anne HEPBURN, GSK Biologicals Michel DETHEUX, Euroscreen Emmanuel LE POUL, Addex Pharmaceuticals David GALL, ULB Magali WAELBROECK, ULB Pierre CHATELAIN, UCB
|
|
|
|
|
|
Deadline for Abstracts:
|
|
no abstracts
|
|
|
|
|
|
Registration:
|
|
http://www.ulb.ac.be/medecine/pharmed
|
|
E-mail:
|
|
Pharmed@ulb.ac.be
|
|
|
|
|
|
|
|